首页> 外文OA文献 >Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study

【2h】

Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study

机译：开发和验证模型预测中度强度他汀类药物治疗2型糖尿病患者的绝对血管风险降低：英国斯堪的纳维亚心脏病预后试验，抗高血压和降脂治疗以预防心脏病发作试验和协同阿托伐他汀糖尿病研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Kaasenbrood, L; Poulter, NR; Sever, PS; Colhoun, HM; Livingstone, SJ; Boekholdt, SM; Pressel, SL; Davis, BR; Van der Graaf, Y; Visseren, FL;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种 eng
中图分类
入库时间 2022-08-20 21:06:53

相似文献

外文文献
中文文献

1. Perspectives from the antihypertensive and lipid-lowering treatment to prevent heart attack trial - lipid lowering trial and the anglo-scandinavian cardiac outcomes trial - lipid lowering arm. [J] . Brown WV, Moussa M Current opinion in lipidology . 2003,第6期

机译：从降压和降脂治疗预防心脏病发作的观点出发-降脂试验和盎格鲁-斯堪的纳维亚心脏结局试验-降脂臂。
2. Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA). [J] . Ostergren J Diabetes care . 2005,第5期

机译：阿托伐他汀在2,532例2型糖尿病患者中的心血管事件减少：盎格鲁-斯堪的纳维亚人的心脏结果降脂试验（ASCOT-LLA）。
3. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension. [J] . Sever PS, Poulter NR, Dahlof B, Journal of hypertension . 2009,第5期

机译：降压疗法和盎格鲁-斯堪的纳维亚人心脏结局试验中阿托伐他汀的益处：降脂臂伸。
4. Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT) [O] . Michael H. Alderman, Barry R. Davis, Linda B. Piller, -1

机译：患有和不患有冠心病的患者抗高血压治疗的建议是否应有所不同？（从降压和降脂治疗预防心脏病发作的试验ALLHAT）
5. Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study [O] . Kaasenbrood, Lotte, Poulter, Neil R., Sever, Peter S., 2016

机译：2型糖尿病患者通过中等强度他汀类药物疗法绝对降低血管风险的预测模型的开发和验证：盎格鲁斯堪的纳维亚心脏试验，抗高血压和降脂治疗可预防心脏病发作和阿托伐他汀协同糖尿病研究

著录项

相似文献

相关主题

期刊订阅